Fundz

Immunic reported raising $60 Million in an initial SEC Form D filing, from an offering of $60 Million

PUBLIC · IMUXOct 18, 2022

Amount Raised

$60 Million

$60 Million sold, per SEC Form D (first sale Oct 10, 2022)

Round Type

Venture

New YorkBiotechnology

Quick answer

Immunic raised $60 Million in a funding round, dated October 10, 2022. Immunic is based in New York, New York, United States.

How much did Immunic raise?
Immunic raised $60 Million in a funding round on October 10, 2022.
What does Immunic do?
Immunic, Inc. is a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases.
Where is Immunic based and how big is it?
Immunic is based in New York, New York, United States. Fundz records about 109 employees.
Who are the decision-makers at Immunic?
Fundz holds 2 contacts at Immunic, including the President and Chief Operating Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Immunic that raised within 45 days of this round, from Fundz verified event records.

  • Hemispherian AS raised an undisclosed amount (Series A) on November 24, 2022.
  • Secretome Therapeutics raised $6.9M on November 23, 2022.
  • Nyra Medical raised $20M (Series A) on November 23, 2022.
  • Kiyatec Inc. raised $18M on November 23, 2022.
  • CatalYm raised $51M (Series C) on November 22, 2022.
  • Empatica raised an undisclosed amount (Series B) on November 22, 2022.

Who to call at Immunic, and when

A new round usually means Immunic is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Immunic raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Immunic, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Immunic. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Immunic

Location

1200 Avenue Of The Americas

New York, New York, United States

About

Immunic, Inc. is a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases. The company focuses on building a leading multiple sclerosis organization as it prepares for potential regulatory filings and commercialization efforts.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Immunic raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJason T., President and Chief Operating Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Immunic's next move

See what Strategic adds

Immunic raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.